---
$id: https://graph.org.ai/products/commodity/51161543
$type: Product
source: UNSPSC
code: "51161543"
title: "Oxarbazole"
class: "51161500"
classTitle: "Antiasthmatic drugs"
family: "51160000"
familyTitle: "Drugs affecting the respiratory tract"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Oxarbazole

**UNSPSC Code**: 51161543
**Class**: [Antiasthmatic drugs](Antiasthmatic drugs.mdx)
**Family**: [Drugs affecting the respiratory tract](../Drugs affecting the respiratory tract.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anti-asthmatic agent with the molecular formula C21H19NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier A34YCH7N8A, chemically known as 9-benzoyl-1,2,3,4-tetrahydro-6-methoxycarbazole-3-carboxylic acid but generally known as oxarbazole, which bears US NIH Compound Identifier 37184. European Medicines Agency schedules Oxarbazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09503MIG. The term OXARBAZOLE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 32, No 10 1978, List 18). OXARBAZOLE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule oxarbazole under HS 29339990 and SITC 51577. As of Q4 2014, OXARBAZOLE remains the US FDA Preferred Term for this commodity. Oxarbazole bears US NLM identifiers UMLS ID C0069741 and NCI Concept Code C81436. SMILES: OC(=O)C1CC2C(N(C3C2CC(OC)CC3)C(=O)C2CCCCC2)CC1.

